Ming-HsiWangMDPhD
Gastroenterology • Mankato, MNAdvanced Endoscopic Interventional, Inflammatory Bowel Disease
Staff Gastroenterologist
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1025 Marsh St
Mankato, MN 56001Phone+1 507-625-4031Fax+1 507-422-0976
Education & Training
Cleveland Clinic FoundationFellowship, Gastroenterology, 2011 - 2014
St Agnes HealthCareResidency, Internal Medicine, 2008 - 2011
National Taiwan University College of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2015 - 2027
MN State Medical License 2015 - 2025
MD State Medical License 2018 - 2019
ME State Medical License 2018 - 2019
OH State Medical License 2011 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis. Start of enrollment: 2017 Dec 25
Publications & Presentations
PubMed
- 1 citationsPolygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease.Ming-Hsi Wang, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha
BMJ Open Gastroenterology. 2023-10-01 - 1 citationsNovel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis.Ming-Hsi Wang, Jessica J Friton, Nancy Rebert, Kelly Monroe, Billy D Nix
Clinical and Translational Gastroenterology. 2023-09-01 - 5 citationsNovel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients.Ming-Hsi Wang, Jessica Friton, Laura E. Raffals, Jonathan A. Leighton, Shabana F. Pasha
Inflammatory Bowel Diseases. 2021-11-15
Press Mentions
Nonsteroidal Anti-Inflammatory Drug-Induced Protein-Losing Enteropathy: A Great Masquerade of Crohn’s DiseaseMay 26th, 2017
Professional Memberships
- Associate
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
